RxDoctor Payments Data

Phillip Fisher, MD

Family Medicine · Sylvania, OHNPI 1043298250

Payments from drug & device makers

$9,015in general payments, 2019–2025

Across 534 payments — averaging $16.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Pfizer$1K
  • Novo Nordisk$1K
  • AbbVie$1K
  • Lilly USA, LLC$538
  • Boehringer Ingelheim$517
  • plus $3K from 41 others

What the payments were for

  • Food & beverage$8,91599%
  • Education$1001%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,015 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$97,899
Medicare patients
283
Services billed
122,421

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide88$114,395
EliquisApixaban104$100,339
JardianceEmpagliflozin44$56,211
FarxigaDapagliflozin Propanediol35$43,748
TrulicityDulaglutide25$35,086
XareltoRivaroxaban33$29,580
EntrestoSacubitril/Valsartan21$24,621
RybelsusSemaglutide17$21,308
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$17,153
Breo ElliptaFluticasone/Vilanterol24$14,593
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog24$13,533
TradjentaLinagliptin11$13,446
JanuviaSitagliptin Phosphate19$12,886
Xtampza ErOxycodone Myristate12$8,697
Bydureon BciseExenatide Microspheres11$8,406

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,108$135,703105 claims
PfizerEliquis$1,136$100,339104 claims
Boehringer IngelheimJardiance, Tradjenta$517$69,65755 claims
AstraZenecaFarxiga$1,178$43,74835 claims
Lilly USA, LLCTrulicity$538$35,08625 claims
GSKTrelegy Ellipta, Breo Ellipta$201$31,74539 claims
Johnson & JohnsonXarelto$163$29,58033 claims
NovartisEntresto$146$24,62121 claims
MerckJanuvia$98$12,88619 claims
AbbVieSynthroid, Armour Thyroid$1,039$4,88572 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Sylvania

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →